Abstract: The disclosure relates to the use of clofoctol in the prevention or treatment of a disease caused by a coronavirus, in particular Covid-19.
Type:
Application
Filed:
June 8, 2021
Publication date:
July 27, 2023
Applicants:
Apteeus, Universite De Lille, Centre National De La Recherche Scientifique, Institut National De La Sante Et De La Recherche Medicale, Centre Hospitalier Universitaire De Lille
Abstract: The invention relates to a system for electroencephalographic detection of an improper adjustment of a ventilator used on a mammal. The system includes an electroencephalograph, capable of measuring, as a function of time, an electroencephalographic signal representative of a breathing process; and an input for receiving a respiratory initiation signal, different from the electroencephalographic signal, capable of indicating a respiratory initiation time. The detection system further includes means for specifying a beta frequency band comprised between 15 and 30 Hz and with a width comprising between 5 and 10 Hz; means for processing the measured electroencephalographic signal, configured for processing the measured electroencephalographic signal as it is being acquired, in the sole specified beta frequency band; and means for identifying, for each breathing cycle, an improper adjustment of the ventilator from the electroencephalographic signals processed in the sole beta frequency band.
Type:
Grant
Filed:
July 6, 2011
Date of Patent:
November 7, 2017
Assignees:
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE LILLE 2 DROIT ET SANTE, CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE
Inventors:
Thomas Similowski, Mathieu Raux, Louise Tyvaert
Abstract: The present invention concerns an in vitro method for diagnosing invasive candidiasis (IC) in a subject which comprises detecting the presence of a Candida glycan and detecting the presence of antibody directed against a protein selected from the group consisting of fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in a blood, plasma or serum sample of the subject. The invention also relates to a method of determining a suitable treatment regimen for a patient and to a kit for implanting the methods described herein.
Type:
Grant
Filed:
March 18, 2013
Date of Patent:
October 3, 2017
Assignees:
Bio-Rad Innovations, Centre Hospitalier Universitaire De Lille, Universite Lille 2 Droit et Sante
Inventors:
Sebastien Damiens, Chantal Fradin, Daniel Poulain, Boualem Sendid, Marc Charles Victor Tabouret
Abstract: The invention relates to a system for electroencephalographic detection of an improper adjustment of a ventilator used on a mammal. The system includes an electroencephalograph, capable of measuring, as a function of time, an electroencephalographic signal representative of a breathing process; and an input for receiving a respiratory initiation signal, different from the electroencephalographic signal, capable of indicating a respiratory initiation time. The detection system further includes means for specifying a beta frequency band comprised between 15 and 30 Hz and with a width comprising between 5 and 10 Hz; means for processing the measured electroencephalographic signal, configured for processing the measured electroencephalographic signal as it is being acquired, in the sole specified beta frequency band; and means for identifying, for each breathing cycle, an improper adjustment of the ventilator from the electroencephalographic signals processed in the sole beta frequency band.
Type:
Application
Filed:
July 6, 2011
Publication date:
August 8, 2013
Applicants:
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE, UNIVERSITE LILLE 2 DROIT ET SANTE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
Inventors:
Thomas Similowski, Mathieu Raux, Louise Tyvaert